Sign In
Buy CRL
$179.87
+5.08 (+2.91%)
At Close: Jun 03, 2026
6 Reasons Why You Should Bet on Charles River (CRAI) Stock
12:30pm, Tuesday, 07'th Sep 2021
Business diversification and investor-friendly moves aid Charles River (CRAI) stock.
Why Charles River (CRAI) Stock Might be a Great Pick
09:54am, Friday, 03'rd Sep 2021
Charles River (CRAI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
These Top Stocks Are Leading The S&P 500 To New Highs In 2021
11:49am, Thursday, 02'nd Sep 2021
Shares of vaccine-maker Moderna have skyrocketed more than 270% this year.
You Won't Believe the Risk This Healthcare Company Faces
07:30am, Saturday, 21'st Aug 2021
It's older than the dinosaurs.
Charles River (CRL) at a 52-Week High: What's Driving It?
10:45am, Thursday, 19'th Aug 2021
Charles River (CRL) ended the second quarter on a strong note with solid performance by the RMS, DSA and Manufacturing Support arms driving the top line.
Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q2 2021 Results - Earnings Call Transcript
11:10pm, Wednesday, 04'th Aug 2021
Charles River Laboratories International, Inc. (CRL) CEO Jim Foster on Q2 2021 Results - Earnings Call Transcript
Charles River (CRL) Q2 Earnings Beat Estimates, 2021 View Up
10:43am, Wednesday, 04'th Aug 2021
Robust performance by all three segments drove Charles River's (CRL) revenues in the second quarter.
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates
09:55am, Wednesday, 04'th Aug 2021
Charles River (CRL) delivered earnings and revenue surprises of 9.21% and 5.17%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Charles River Q2 Earnings
07:49am, Wednesday, 04'th Aug 2021
Shares of Charles River (NYSE:CRL) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share increased 65.19% year over year to $2.61, which beat the estimate of $2.38
Reasons to Retain Charles River (CRAI) in Your Portfolio
12:02pm, Friday, 09'th Jul 2021
Charles River (CRAI) has a diversified business with service offerings across areas of functional expertise, client base and geographical regions.
10 Top-Ranked Stocks Powering S&P 500 ETF
12:02pm, Thursday, 08'th Jul 2021
The S&P 500 has been outperforming this year due to the strength in value and cyclical stocks, which were battered last year in the pandemic.
What's Next For Charles River Laboratories Stock After A 13% Rise Last Month?
09:20am, Wednesday, 07'th Jul 2021
The stock price of Charles River Laboratories, a company that offers clinical laboratory, gene therapy, and cell therapy services for the pharmaceuticals industry, has seen a 13% rise over the last
Charles River (CRL) Advances in Gene Therapy With Vigene Buyout
10:18am, Wednesday, 30'th Jun 2021
The consolidation between Charles River (CRL) and Vigene is set to establish an end-to-end, gene-modified cell therapy solution in the United States.
What Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?
12:47pm, Tuesday, 22'nd Jun 2021
Does Charles River Laboratories (CRL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Charles River Laboratories: Stick With What Has Been Working
01:44pm, Monday, 21'st Jun 2021
Charles River's stock has significantly outperformed the S&P 500 over the last 1-,3- and 5-year periods. Better yet, Charles River is well-positioned for 2021 and beyond, as I believe the future for t
